1.3352.55% ( -0.035 )
Delay Closed: Nov 16, 16:08:00Valuation
Current ValuationThe current P/E ratio is -1.82, above the reasonable range, cheaper than 9.36% of the time in the past 5 years, and the industry ranks 9/12, the industry Median 9.30.
-1.82xP/E
HK$1.34Stock price
HK$-0.73Earnings per share
-1.82xP/E
Stock priceHK$1.34Earnings per shareHK$-0.73
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- -3.19x
- Typical range
- -7.33x–-2.20x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 9.30x
07142128
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 9.30x
0x10x20x30x40x50x
| Name/Symbol | |||
|---|---|---|---|
02170HKBASECARE-B | -1.82x | 27.39% | HK$364.39M |
08622HKJOYZYME GROUP | -26.50x | -- | HK$152.06M |
00876HKQH BIO PHARMA | -1.53x | -- | HK$151.30M |
02393HKYESTAR HEALTH | -1.18x | -- | HK$114.25M |
01134HKKELFRED | -4.59x | -- | HK$102.50M |
08513HKMAXWIN INT HLDG | -10.65x | -- | HK$26.19M |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
